Mark S Nestor1, Nicole Swenson2, Angela Macri2, Mitchell Manway2, Paige Paparone2. 1. Center for Clinical and Cosmetic Research and Center for Cosmetic Enhancement, Aventura, Florida;; Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida. 2. Center for Clinical and Cosmetic Research and Center for Cosmetic Enhancement, Aventura, Florida;
Abstract
OBJECTIVE: To evaluate the efficacy and tolerance of a combined 445nm/630nm light therapy mask for the treatment of mild-to-moderate acne vulgaris with and without topical 1% salicylic acid with retinol versus 2.5% benzoyl peroxide. DESIGN: A 12-week evaluator-blinded, randomized study. Subjects were randomized to be treated with the 445nm/630nm light therapy mask alone, benzoyl peroxide, or 445nm/630nm light therapy mask with topical 1% salicylic acid with retinol. PARTICIPANTS: Healthy male and female subjects 12 to 35 years old with Fitzpatrick skin types I to VI and mild-to-moderate facial acne vulgaris. MEASUREMENTS: The primary endpoint was the change in the number of inflammatory acne lesions after 12 weeks of treatment. Secondary endpoints included the change in noninflammatory acne lesions, change in total acne lesions, change in Investigator Global Acne Assessments, and overall responder rate. RESULTS:445nm/630nm light therapy mask-treated subjects showed a 24.4-percent improvement in inflammatory acne lesions (p<0.01) versus 17.2 percent (p<0.05) and 22.7 percent (p<0.01) in benzoyl peroxide and 445nm/630nm light therapy mask with topical 1% salicylic acid with retinol, respectively, a 19.5-percent improvement in noninflammatory lesions (p<0.001) versus 6.3 and 4.8 percent for benzoyl peroxide and 445nm/630nm light therapy mask with topical 1% salicylic acid with retinol, respectively. Subjects in the 445nm/630nm light therapy mask group also achieved a 19.0-percent improvement in the Investigator Global Acne Assessment (p<0.001) versus 4.7 percent in benzoyl peroxide and 13.9 percent in 445nm/630nm light therapy mask with topical 1% salicylic acid with retinol (p<0.01). Treatments were well-tolerated overall with trends toward less early irritation in the 445nm/630nm light therapy mask group. CONCLUSION:445nm/630nm light therapy mask appears to be a safe and effective therapy for mild-to-moderate acne.
RCT Entities:
OBJECTIVE: To evaluate the efficacy and tolerance of a combined 445nm/630nm light therapy mask for the treatment of mild-to-moderate acne vulgaris with and without topical 1% salicylic acid with retinol versus 2.5% benzoyl peroxide. DESIGN: A 12-week evaluator-blinded, randomized study. Subjects were randomized to be treated with the 445nm/630nm light therapy mask alone, benzoyl peroxide, or 445nm/630nm light therapy mask with topical 1% salicylic acid with retinol. PARTICIPANTS: Healthy male and female subjects 12 to 35 years old with Fitzpatrick skin types I to VI and mild-to-moderate facial acne vulgaris. MEASUREMENTS: The primary endpoint was the change in the number of inflammatory acne lesions after 12 weeks of treatment. Secondary endpoints included the change in noninflammatory acne lesions, change in total acne lesions, change in Investigator Global Acne Assessments, and overall responder rate. RESULTS: 445nm/630nm light therapy mask-treated subjects showed a 24.4-percent improvement in inflammatory acne lesions (p<0.01) versus 17.2 percent (p<0.05) and 22.7 percent (p<0.01) in benzoyl peroxide and 445nm/630nm light therapy mask with topical 1% salicylic acid with retinol, respectively, a 19.5-percent improvement in noninflammatory lesions (p<0.001) versus 6.3 and 4.8 percent for benzoyl peroxide and 445nm/630nm light therapy mask with topical 1% salicylic acid with retinol, respectively. Subjects in the 445nm/630nm light therapy mask group also achieved a 19.0-percent improvement in the Investigator Global Acne Assessment (p<0.001) versus 4.7 percent in benzoyl peroxide and 13.9 percent in 445nm/630nm light therapy mask with topical 1% salicylic acid with retinol (p<0.01). Treatments were well-tolerated overall with trends toward less early irritation in the 445nm/630nm light therapy mask group. CONCLUSION: 445nm/630nm light therapy mask appears to be a safe and effective therapy for mild-to-moderate acne.
Authors: Mollie D Oudenhoven; Megan A Kinney; Diana B McShane; Craig N Burkhart; Dean S Morrell Journal: Am J Clin Dermatol Date: 2015-08 Impact factor: 7.403
Authors: Aikaterini Charakida; Edward D Seaton; Marietta Charakida; Paul Mouser; Antonias Avgerinos; Antony C Chu Journal: Am J Clin Dermatol Date: 2004 Impact factor: 7.403
Authors: Daniel R Opel; Erika Hagstrom; Aaron K Pace; Krisanne Sisto; Stefanie A Hirano-Ali; Shraddha Desai; James Swan Journal: J Clin Aesthet Dermatol Date: 2015-06
Authors: Jelena Barbaric; Rachel Abbott; Pawel Posadzki; Mate Car; Laura H Gunn; Alison M Layton; Azeem Majeed; Josip Car Journal: Cochrane Database Syst Rev Date: 2016-09-27
Authors: Anna Mae Scott; Paulina Stehlik; Justin Clark; Dexing Zhang; Zuyao Yang; Tammy Hoffmann; Chris Del Mar; Paul Glasziou Journal: Ann Fam Med Date: 2019-11 Impact factor: 5.166
Authors: Jared Jagdeo; Evan Austin; Andrew Mamalis; Christopher Wong; Derek Ho; Daniel M Siegel Journal: Lasers Surg Med Date: 2018-01-22 Impact factor: 4.025